Amicus Therapeutics, Inc.

Direct answer

Amicus Therapeutics, Inc. is publicly traded on NASDAQ under the ticker FOLD.

Amicus Therapeutics, Inc. is a biotechnology firm dedicated to the discovery, development, and delivery of medical treatments for rare conditions. Its primary commercial offering is Galafold, an orally administered precision medicine designed for adult patients with a confirmed diagnosis of Fabry disease, specifically those exhibiting an amenable galactosidase alpha gene variant as identified by in vitro assay data....

Can you invest in Amicus Therapeutics, Inc.?

Yes. Amicus Therapeutics, Inc. trades publicly on NASDAQ as FOLD.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Amicus Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.